Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Clinical trial NCT00877877 · COMPLETED

Trial details

NCT number: NCT00877877
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Papillomavirus Papillomavirus Vaccines

Start date: 2009-05-07
Primary completion: 2015-01-06
Enrollment: 632

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.